1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 309-312

  Riek, Amy E ^a   Oh, Jisu ^a   Bernal Mizrachi, Carlos ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol metabolism; Diabetes; ER stress; Macrophage phenotype; Migration; Vitamin D

Indexed keywords

CALCITRIOL; CHEMOKINE RECEPTOR CCR2; CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; THAPSIGARGIN;

ATHEROGENESIS; CELL DIFFERENTIATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; ENDOPLASMIC RETICULUM STRESS; HUMAN; MACROPHAGE; MACROPHAGE MIGRATION; MACROPHAGE MIGRATION INHIBITION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

EID: 84881146855     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.12.019     Document Type: Review

References (19)

1. G. Isaia, R. Giorgino, S. Adami, High prevalence of hypovitaminosis D in female type 2 diabetic population, Diabetes Care 24 (8) (2001) 1496.
2. M. Cigolini, M.P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, G. Targher, Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients, Diabetes Care 29 (3) (2006) 722-724.
3. T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D'Agostino, M. Wolf, R.S. Vasan, Vitamin, D deficiency and risk of cardiovascular disease, Circulation 117 (4) (2008) 503-511.
4. K.C. Chiu, A. Chu, V.L. Go, M.F. Saad, Hypovitaminosis, D is associated with insulin resistance and beta cell dysfunction, American Journal of Clinical Nutrition 79 (5) (2004) 820-825.
5. Y.C. Li, J. Kong, M. Wei, Z.F. Chen, S.Q. Liu, L.P. Cao, 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system, Journal of Clinical Investigation 110 (2) (2002) 229-238.
6. A. Giulietti, E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, C. Mathieu, Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D(3) works as anti-inflammatory, Diabetes Research and Clinical Practice 77 (1) (2007) 47-57.
7. J. Oh, S. Weng, S.K. Felton, S. Bhandare, A. Riek, B. Butler, B.M. Proctor, M. Petty, Z. Chen, K.B. Schechtman, L. Bernal-Mizrachi, C. Bernal-Mizrachi, 1 25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus, Circulation 120 (8) (2009) 687-698.
8. S. Potteaux, E.L. Gautier, S.B. Hutchison, N. van Rooijen, D.J. Rader, M.J. Thomas, M.G. Sorci-Thomas, G.J. Randolph, Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression, The Journal of Clinical Investigation 121 (5) (2011) 2025-2036.
9. E. Trogan, J.E. Feig, S. Dogan, G.H. Rothblat, V. Angeli, F. Tacke, G.J. Randolph, E.A. Fisher, Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice, Proceedings of the National Academy of Sciences of the United States of America 103 (10) (2006) 3781-3786.
10. F. Tacke, D. Alvarez, T.J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, S.A. Lira, A.J. Habenicht, G.J. Randolph, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques, Journal of Clinical Investigation 117 (1) (2007) 185-194.
11. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, M. Locati, The chemokine system in diverse forms of macrophage activation and polarization, Trends in Immunology 25 (12) (2004) 677-686.
12. S. Gordon, Alternative activation of macrophages, Nature Reviews. Immunology 3 (1) (2003) 23-35.
13. F.O. Martinez, S. Gordon, M. Locati, A. Mantovani, Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression, Journal of Immunology 177 (10) (2006) 7303-7311.
14. J. Oh, A.E. Riek, S. Weng, M. Petty, D. Kim, M. Colonna, M. Cella, C. Bernal-Mizrachi, Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation, Journal of Biological Chemistry 287 (15) (2012) 11629-11641.
15. J. Khallou-Laschet, A. Varthaman, G. Fornasa, C. Compain, A.T. Gaston, M. Clement, M. Dussiot, O. Levillain, S. Graff-Dubois, A. Nicoletti, G. Caligiuri, Macrophage plasticity in experimental atherosclerosis, PLoS ONE 5 (1) (2010)e8852.
16. A.E. Riek, J. Oh, J.E. Sprague, A. Timpson, L. de Las Fuentes, L. Bernal-Mizrachi, K.B. Schechtman, C. Bernal-Mizrachi, Vitamin D suppression of endoplasmic reticulum stress promotes an anti-atherogenic monocyte/macrophage phenotype in type 2 diabetic patients, Journal of Biological Chemistry (2012).
17. P.S. Jellinger, D.A. Smith, A.E. Mehta, O. Ganda, Y. Handelsman, H.W. Rodbard, M.D. Shepherd, J.A. Seibel, R. Kreisberg, R. Goldberg, American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis, Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 18 (Suppl. 1) (2012) 1-78.
18. E.M. Rubin, R.M. Krauss, E.A. Spangler, J.G. Verstuyft, S.M. Clift, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature 353 (6341) (1991) 265-267.
19. M.L. Armstrong, Evidence of regression of atherosclerosis in primates and man, Postgraduate Medical Journal 52 (609) (1976) 456-461.